ENXTPA:ABVXBiotechs
ABIVAX Royalty Buyback Clears Future Claims And Refocuses Shareholder Upside
ABIVAX Société Anonyme (ENXTPA:ABVX) completed a $90 million transaction to repurchase all existing royalty certificates.
The repurchased royalty certificates are being cancelled, removing future royalty obligations linked to them.
This transaction simplifies the company’s capital structure ahead of potential commercialization of its pipeline.
ABIVAX, listed as ENXTPA:ABVX, focuses on developing therapies in the biopharma space, where funding structures and future payment obligations can be...